CATEGORY : Genomics Market

Life Science Market Reports

Our life science market intelligence products have been recognized by market insiders and outsiders alike for their accuracy, in-depth analysis, and unique insights.

Market Reports

The Follower’s Advantage: Cases in Life Science Research Tool Markets

The first mover’s advantage is a widespread concept in business. The idea is that a company can gain a competitive advantage by being the first to enter into an untapped

Spatial Omics Year in Review

2019 was a big year for the spatial omics market—we saw a number of long-awaited commercial launches and new product offerings, among other exciting news in the field. This blog

Select 2019 Trends and Discussions

  Los Angeles, CA January 3, 2019 – The end the last decade deepened my personal belief that the personalized medicine revolution will be driven by tools and diagnostics, rather

QIAGEN to Become Thermo?

In mid-November, speculation began that ThermoFisher was in talks with QIAGEN surrounding a potential acquisition. A hypothetical tie-up could help Thermo bolster its reach into clinical diagnostic tests and nucleic

Dx FTW

Los Angeles, CA November 26, 2019 – At DeciBio, we believe that the precision medicine revolution will be driven by improvements in life science research tools and diagnostics technologies! A

Pain Points, Unmet Needs, and Disruption in Precision Medicine – Part 1

DeciBio’s mission is to provide market intelligence and strategic insights that drive disruption and innovation in the precision medicine and life science industry. To this end, my colleague, Colin Enderlein,

Highly-Multiplexed Tissue Imaging: The Research Tool of The Future

In our last blog post, Andrew covered how immuno-oncology is driving the development and utilization of digital pathology and multiplex spatial tissue analysis. In his blog, Andrew included all plex

Pulse Survey: Adoption and Utilization of Next Generation Cancer Biomarkers

The way cancer is diagnosed, treated, and monitored is changing more rapidly than ever. In 2019, we expect there to be catalysts that fundamentally change cancer companion diagnostic biomarker testing (i.e.,

Three lessons for digital health entrepreneurs from #RHSUM18

This year’s Rock Health annual digital health summit showcased another impressive lineup, with speakers like Bernard Tyson (CEO of Kaiser Permanente), Toby Cosgrove (Executive Adviser for Google Cloud and former